The supplemental data file was not included in the article at the time of publication. It has since been added.
. 2022 Mar 2;6(5):1489. doi: 10.1182/bloodadvances.2022007186
Tiong IS, Dillon R, Ivey A, et al. Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia. Blood Adv. 2021;5(23):5107-5111.
Collection date 2022 Mar 8.
© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
PMCID: PMC8905710 PMID: 35238914
This corrects the article "Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia" in volume 5 on page 5107.